A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis.
第一作者:
Philip N,Newsome
第一单位:
National Institute for Health Research, Birmingham Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. p.n.newsome@bham.ac.uk.;Centre for Liver & Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. p.n.newsome@bham.ac.uk.
作者:
医学主题词
成年人(Adult);人类(Humans);半胱氨酸天冬氨酸蛋白酶(Caspases);双盲法(Double-Blind Method);治疗结果(Treatment Outcome);胺氧化酶(含铜)(Amine Oxidase (Copper-Containing))
DOI
10.1038/s41467-023-42398-w
PMID
37932258
发布时间
2023-11-28
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



